- Home
- NBBK vs CATX Comparison
NBBK vs CATX Comparison
Compare NBBK & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBBK
- CATX
- Stock Information
- Founded
- NBBK 1892
- CATX 1983
- Country
- NBBK United States
- CATX United States
- Employees
- NBBK N/A
- CATX N/A
- Industry
- NBBK
- CATX Medical/Dental Instruments
- Sector
- NBBK
- CATX Health Care
- Exchange
- NBBK Nasdaq
- CATX Nasdaq
- Market Cap
- NBBK 783.2M
- CATX 782.7M
- IPO Year
- NBBK N/A
- CATX N/A
- Fundamental
- Price
- NBBK $20.30
- CATX $3.48
- Analyst Decision
- NBBK Buy
- CATX Strong Buy
- Analyst Count
- NBBK 1
- CATX 9
- Target Price
- NBBK $22.00
- CATX $21.63
- AVG Volume (30 Days)
- NBBK 160.3K
- CATX 838.3K
- Earning Date
- NBBK 10-30-2024
- CATX 11-12-2024
- Dividend Yield
- NBBK N/A
- CATX N/A
- EPS Growth
- NBBK N/A
- CATX N/A
- EPS
- NBBK 0.30
- CATX N/A
- Revenue
- NBBK $146,994,000.00
- CATX $1,557,000.00
- Revenue This Year
- NBBK N/A
- CATX N/A
- Revenue Next Year
- NBBK N/A
- CATX N/A
- P/E Ratio
- NBBK $67.20
- CATX N/A
- Revenue Growth
- NBBK 11.94
- CATX N/A
- 52 Week Low
- NBBK $13.10
- CATX $2.30
- 52 Week High
- NBBK $20.98
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- NBBK 58.58
- CATX 10.37
- Support Level
- NBBK $19.51
- CATX $11.40
- Resistance Level
- NBBK $20.97
- CATX $12.82
- Average True Range (ATR)
- NBBK 0.54
- CATX 0.83
- MACD
- NBBK -0.04
- CATX -0.68
- Stochastic Oscillator
- NBBK 65.76
- CATX 0.00
About NBBK NB Bancorp Inc.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.